Skip to content
Clinical Trials – home

Ambulatory of specialized outpatient medical help in internal diseases and cardiology Individual practice Cardio Tonus EOOD

Research site

Bulgaria Druzhba II Bl 284 Ent А Fl 0 Ap М14 5, District Iskar, 1582 Sofia, Bulgaria

  • 4 trials recruiting
  • Cardiac failure · Cardiovascular disorder · Hypertension
  • Adult patients

About Specializations

Ambulatory of specialized outpatient medical help in internal diseases and cardiology Individual practice Cardio Tonus EOOD in Sofia, Bulgaria specialises in clinical trials of conditions such as Cardiac failure, Cardiovascular disorder, Hypertension, Hypertriglyceridaemia, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Research

The medical center is at the forefront of cardiovascular research, focusing on innovative treatments for lipid disorders. The center's work in this field is pivotal in understanding and managing conditions that affect heart health.

  • Hyperlipidemia
  • Triglyceride Management
  • Cardiovascular Risk Reduction

By exploring novel therapeutic approaches, the center contributes significantly to reducing the burden of cardiovascular diseases globally.

Endocrinology and Metabolism

Specializing in endocrinology and metabolism, the center conducts cutting-edge research on metabolic disorders, particularly focusing on severe hypertriglyceridemia. This research is crucial for developing effective interventions for metabolic health.

  • Severe Hypertriglyceridemia
  • Metabolic Syndrome
  • Insulin Resistance

The center's efforts in this area aim to improve patient outcomes through targeted therapies and personalized medicine.

Clinical Pharmacology

The institution excels in clinical pharmacology, focusing on the development and evaluation of new pharmacological agents. This research is essential for advancing therapeutic options and ensuring drug safety and efficacy.

  • Drug Development
  • Pharmacokinetics
  • Therapeutic Drug Monitoring

Through rigorous clinical trials and research, the center plays a vital role in bringing innovative treatments to the market.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Druzhba II Bl 284 Ent А Fl 0 Ap М14 5, District Iskar1582 SofiaBulgaria
Recruiting now
4 trials
Conditions studied
8

More sites in SofiaBulgaria

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

9 clinical trials

Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Zilebesiran
  • Sponsor:Alnylam Pharmaceuticals Inc.

Study of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:BI 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.

Cardiac failure

Recruiting

Study on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:BI 690517
  • Sponsor:Boehringer Ingelheim International GmbH

Cardiac failure

Recruiting

Evaluating the Effect of Vicadrostat and Empagliflozin Combination Compared to Empagliflozin Alone in Patients with Heart Failure and Reduced Left Ventricular Function

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:BI 690517
  • Sponsor:Boehringer Ingelheim International GmbH

Atrial fibrillation

Not yet recruiting

Prevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Regeneron Pharmaceuticals Inc.

Hypertriglyceridaemia

Not recruiting

Long-Term Safety Study of Plozasiran for Adults with High Triglycerides

InvestigationalNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
  • Sponsor:Arrowhead Pharmaceuticals Inc.

Obesity

Not recruiting

Study on the Effect of Survodutide on Heart Safety in Patients with Obesity and Cardiovascular or Kidney Disease

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:BI 456906
  • Sponsor:Boehringer Ingelheim Espana S.A.

Hypertriglyceridaemia

Not recruiting

Study of Plozasiran for Adults with Severe Hypertriglyceridemia

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
  • Sponsor:Arrowhead Pharmaceuticals Inc.

Arteriosclerosis

Not recruiting

Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Novartis Pharma AG
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.